Drug Information for ERY-TAB (KAISER FOUNDATION HOSPITALS): Pregnancy

  • Teratogenic effectsPregnancy Category B

    There is no evidence of teratogenicity or any other adverse effect on reproduction in female rats fed erythromycin base (up to 0.25 percent of diet) prior to and during mating, during gestation, and through weaning of two successive litters. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

  • Drug Information Provided by National Library of Medicine (NLM).